DongKook Pharmaceuti...
KOSDAQ:A086450
24.650,00
₩-300,00 (-1,20%)
24.650,00
₩-300,00 (-1,20%)
End-of-day quote: 04/23/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

₩1,37k
Earnings Per Share
₩18,47k
Revenue Per Share
55,11%
Gross Margin %
₩1.125,51 B
Market Cap
₩22,90 B
Long-Term Debt
Earnings Per Share
₩1,37k
Revenue Per Share
₩18,47k
Gross Margin %
55,11%
Market Cap
₩1.125,51 B
Long-Term Debt
₩22,90 B

Financials

Year Year 2026 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share ₩1,37k ₩1,06k ₩1,18k ₩1,13k ₩1,25k ₩1,26k ₩1,06k ₩901,00 ₩925,20 ₩624,00 ₩478,40 ₩378,00
Earnings Earnings ₩60,15B ₩46,38B ₩52,00B ₩49,49B ₩54,98B ₩55,34B ₩46,58B ₩39,60B ₩40,66B ₩27,42B ₩21,04B ₩16,79B
RPS Revenue Per Share ₩0,00 ₩18,47k ₩16,63k ₩15,05k ₩13,52k ₩12,72k ₩10,97k ₩9,12k ₩8,07k ₩7,05k ₩5,91k ₩5,14k ₩4,80k
Revenue Revenue ₩0,00M ₩812,17B ₩730,99B ₩661,65B ₩594,19B ₩559,10B ₩482,28B ₩400,81B ₩354,77B ₩309,63B ₩259,93B ₩226,01B ₩213,09B
OCF Operating Cash Flow ₩0,00M ₩76,09B ₩41,79B ₩40,91B ₩44,65B ₩59,11B ₩69,48B ₩0,00M ₩28,66B ₩39,41B ₩27,34B ₩22,74B ₩0,00M
FCF Free Cash Flow ₩0,00M ₩81,50B ₩75,80B ₩-6,26B ₩-6,35B ₩19,50B ₩44,35B ₩0,00M ₩16,99B ₩25,40B ₩18,28B ₩9,14B ₩0,00M
OM Operating Margin 0,00% 9,83% 9,15% 11,11% 10,64% 14,77% 14,25% 13,75% 14,11% 15,15% 12,93% 11,75% 11,53%
GM % Gross Margin % 0,00% 55,11% 56,16% 57,38% 58,89% 60,30% 60,23% 59,30% 58,96% 58,95% 57,00% 56,53% 57,60%
FCFS Free Cash Flow Per Share ₩0,00 ₩1,02k ₩50,11 ₩-251,72 ₩-114,27 ₩405,34 ₩1,01k ₩-963,04 ₩381,58 ₩677,89 ₩403,40 ₩210,40 ₩348,36
LT Debt Long-Term Debt N/A ₩22,90B ₩18,75B ₩25,00B ₩10,00B ₩49,00B ₩41,70B ₩40,12B ₩359,94M ₩482,00M ₩1,48B ₩1,60B ₩700,00M
Sha. Stocks 43,97M 43,97M 43,96M 43,96M 43,95M 43,95M 43,95M 43,95M 43,95M 43,95M 43,95M 43,97M 44,42M
×